ArticleRSC advances2026
Preparation of amorphous calcium phosphate nanoparticles using small organic molecules for biomimetic mineralization of dentin.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of nanomaterials capable of effectively occluding dentinal tubules and inducing biomimetic mineralization is critical for treating dentin hypersensitivity and early-stage caries. Owing to its high reactivity, amorphous calcium phosphate (ACP) serves as an ideal mineralization precursor. Although organic molecules are known to modulate and stabilize ACP, how small organic molecules (SOM) with distinct functional groups influence its remineralization efficacy remains incompletely understood. In this work, phytic acid (IP6) and cyclohexanehexacarboxylic acid (H6L), two structurally analogous yet functionally distinct molecules, were used as regulators to synthesize organic/ACP nanocomposites, denoted as IP6/CaP and H6L/CaP, respectively. A control sample prepared without organic additives was denoted as CaP. These composites were systematically evaluated for their ability to occlude dentinal tubules, promote remineralization, and resist acid challenge, using commercial 45S5 bioactive glass (BG) as a positive control. Material characterization revealed that the CaP comprised hydroxyapatite with an average particle size of 548.75 ± 2.32 nm. In contrast, both IP6 and H6L facilitated the formation of uniformly distributed microscale round-shaped aggregates, yielding IP6/CaP and H6L/CaP with average diameters of 87.64 ± 2.37 nm and 99.56 ± 1.67 nm, respectively.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.